• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[诊断性心脏导管插入术和/或冠状动脉介入术后股动脉穿刺部位的经皮缝合。一种新的动脉缝合技术的安全性和有效性]

[Percutaneous suture of femoral artery access sites after diagnostic heart catheterization and or coronary intervention. Safety and effectiveness of a new arterial suture technic].

作者信息

Gerckens U, Cattelaens N, Müller R, Lampe E G, Grube E

机构信息

Medizinische Klinik, Kardiologie, Krankenhaus Siegburg.

出版信息

Herz. 1998 Feb;23(1):27-34. doi: 10.1007/BF03043009.

DOI:10.1007/BF03043009
PMID:9541845
Abstract

UNLABELLED

The safety and efficacy of a suture-based closure device designed to achieve hemostasis at the femoral access site post catheterization procedures was compared to manual compression in a 600 patients randomized trial (data available for 590 patients). The patients were randomized to percutaneous vascular surgery (PVS) or manual compression after diagnostic (401 patients) and interventional (189 patients) procedures. Two types of PVS devices were used delivering 1 or 2 sutures at the arterial access site. The overall results as well as the results by procedure type demonstrated a significant reduction in time of hemostasis (7.8 +/- 4.8 min vs 19.6 +/- 13.2 min, p < 0.01) and time to ambulation (4.5 +/- 6.5 hours vs 17.8 +/- 5.0 hours, p < 0.01) with the use of the PVS device. The safety results showed no significant differences in the incidence of vascular complications (5.7% for PVS vs 11.3% for compression) in the overall population or in the interventional patients subset (8.4% for PVS vs 9.6% for compression). However, the PVS device demonstrated a significant reduction in the incidence of vascular complications post diagnostic catheterization procedures (4.4 for PVS vs 12.1% for compression, p < 0.05). The incidence of vascular complications and the time of hemostasis was similar in an American multicenter study (STAND II).

CONCLUSION

Percutaneous vascular surgery is a safe and effective method to achieve hemostasis post catheterization procedure providing faster hemostasis and ambulation without increasing the rate of complication.

摘要

未标注

在一项纳入600例患者的随机试验(590例患者有可用数据)中,将一种用于在导管插入术后实现股动脉穿刺部位止血的缝线闭合装置的安全性和有效性与手动压迫进行了比较。患者在诊断性(401例患者)和介入性(189例患者)操作后被随机分为接受经皮血管手术(PVS)或手动压迫。使用了两种类型的PVS装置,在动脉穿刺部位缝合1或2针。总体结果以及按操作类型的结果显示,使用PVS装置可显著缩短止血时间(7.8±4.8分钟对19.6±13.2分钟,p<0.01)和下床活动时间(4.5±6.5小时对17.8±5.0小时,p<0.01)。安全性结果显示,总体人群或介入患者亚组中血管并发症发生率无显著差异(PVS组为5.7%,压迫组为11.3%)。然而,PVS装置在诊断性导管插入术后血管并发症发生率显著降低(PVS组为4.4%,压迫组为12.1%,p<0.05)。在美国一项多中心研究(STAND II)中,血管并发症发生率和止血时间相似。

结论

经皮血管手术是导管插入术后实现止血的一种安全有效的方法,能更快实现止血和下床活动,且不增加并发症发生率。

相似文献

1
[Percutaneous suture of femoral artery access sites after diagnostic heart catheterization and or coronary intervention. Safety and effectiveness of a new arterial suture technic].[诊断性心脏导管插入术和/或冠状动脉介入术后股动脉穿刺部位的经皮缝合。一种新的动脉缝合技术的安全性和有效性]
Herz. 1998 Feb;23(1):27-34. doi: 10.1007/BF03043009.
2
Management of arterial puncture site after catheterization procedures: evaluating a suture-mediated closure device.导管插入术后动脉穿刺部位的管理:评估一种缝线介导的闭合装置。
Am J Cardiol. 1999 Jun 15;83(12):1658-63. doi: 10.1016/s0002-9149(99)00174-5.
3
Safety and efficacy of clip-based vs. suture mediated vascular closure for femoral access hemostasis: A prospective randomized single center study comparing the StarClose and the ProGlide device.基于夹子与缝线介导的血管闭合用于股动脉穿刺止血的安全性和有效性:一项比较StarClose和ProGlide装置的前瞻性随机单中心研究。
Catheter Cardiovasc Interv. 2018 Feb 15;91(3):402-407. doi: 10.1002/ccd.27116. Epub 2017 May 13.
4
Suture-mediated closure of the femoral access site after cardiac catheterization: results of the suture to ambulate aNd discharge (STAND I and STAND II) trials.心脏导管插入术后缝线介导的股动脉穿刺部位闭合:缝线辅助活动及出院(STAND I和STAND II)试验结果
Am J Cardiol. 2000 Apr 1;85(7):864-9. doi: 10.1016/s0002-9149(99)00882-6.
5
A randomized comparison of a percutaneous suture device versus manual compression for femoral artery hemostasis after PTCA.经皮冠状动脉腔内血管成形术(PTCA)后,使用经皮缝合装置与手动压迫法进行股动脉止血的随机对照研究。
J Interv Cardiol. 2003 Jun;16(3):217-21. doi: 10.1034/j.1600-0854.2003.8044.x.
6
A multicenter randomized trial comparing a percutaneous collagen hemostasis device with conventional manual compression after diagnostic angiography and angioplasty.一项多中心随机试验,比较经皮胶原止血装置与诊断性血管造影和血管成形术后传统手动压迫的效果。
J Invasive Cardiol. 1999 Sep;11 Suppl B:6B-13B.
7
The safety and efficacy of the StarClose Vascular Closure System: the ultrasound substudy of the CLIP study.StarClose血管闭合系统的安全性和有效性:CLIP研究的超声子研究
Catheter Cardiovasc Interv. 2006 Nov;68(5):684-9. doi: 10.1002/ccd.20898.
8
Postinterventional transcutaneous suture of femoral artery access sites in patients with peripheral arterial occlusive disease: a study of 930 patients.
Catheter Cardiovasc Interv. 2001 Jun;53(2):174-81. doi: 10.1002/ccd.1144.
9
Percutaneous suture-mediated closure of femoral access sites deployed through the procedure sheath: initial clinical experience with a novel vascular closure device.经皮缝线介导闭合通过手术鞘置入的股动脉穿刺部位:一种新型血管闭合装置的初步临床经验
Catheter Cardiovasc Interv. 2003 Mar;58(3):313-21. doi: 10.1002/ccd.10472.
10
A multicenter randomized trial comparing a percutaneous collagen hemostasis device with conventional manual compression after diagnostic angiography and angioplasty.一项多中心随机试验,比较诊断性血管造影和血管成形术后经皮胶原蛋白止血装置与传统手动压迫的效果。
J Am Coll Cardiol. 1993 Nov 1;22(5):1273-9. doi: 10.1016/0735-1097(93)90529-a.

引用本文的文献

1
Vascular closure devices for femoral arterial puncture site haemostasis.用于股动脉穿刺部位止血的血管闭合装置。
Cochrane Database Syst Rev. 2016 Mar 7;3(3):CD009541. doi: 10.1002/14651858.CD009541.pub2.
2
Efficacy of femoral vascular closure devices in patients treated with anticoagulant, abciximab or thrombolytics during percutaneous endovascular procedures.经皮血管内介入治疗期间使用抗凝剂、阿昔单抗或溶栓剂治疗的患者中股血管闭合装置的疗效
Korean J Radiol. 2006 Jan-Mar;7(1):35-40. doi: 10.3348/kjr.2006.7.1.35.

本文引用的文献

1
First chronic platelet glycoprotein IIb/IIIa integrin blockade. A randomized, placebo-controlled pilot study of xemilofiban in unstable angina with percutaneous coronary interventions.首次慢性血小板糖蛋白IIb/IIIa整合素阻断。一项关于 xemilofiban 在不稳定型心绞痛经皮冠状动脉介入治疗中的随机、安慰剂对照试验研究。
Circulation. 1997 Jul 1;96(1):76-81. doi: 10.1161/01.cir.96.1.76.
2
Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization.经皮冠状动脉血运重建术中血小板糖蛋白IIb/IIIa受体阻滞剂与低剂量肝素的应用
N Engl J Med. 1997 Jun 12;336(24):1689-96. doi: 10.1056/NEJM199706123362401.
3
[Percutaneous suture closure of the femoral artery access after diagnostic heart catheter examination or coronary intervention].
诊断性心脏导管检查或冠状动脉介入治疗后经皮缝合关闭股动脉入路
Dtsch Med Wochenschr. 1996 Nov 29;121(48):1487-91. doi: 10.1055/s-2008-1043173.
4
Femoral arterial sheath removal after PTCA: a cross-Canada survey.经皮冠状动脉腔内血管成形术后股动脉鞘管拔除:一项全加拿大范围的调查。
Can J Cardiovasc Nurs. 1995;6(3-4):13-9.
5
Vascular complications after balloon and new device angioplasty.球囊及新型器械血管成形术后的血管并发症。
Circulation. 1993 Oct;88(4 Pt 1):1569-78. doi: 10.1161/01.cir.88.4.1569.
6
[Local vascular complications in heart catheter studies].[心脏导管检查中的局部血管并发症]
Z Kardiol. 1993 Jul;82(7):449-56.
7
[Complications after coronary angiography and balloon dilatation].[冠状动脉造影和球囊扩张术后的并发症]
Dtsch Med Wochenschr. 1993 Nov 19;118(46):1669-76. doi: 10.1055/s-2008-1059500.
8
Vascular complications of cardiac catheterization.
Am J Surg. 1994 Apr;167(4):375-8. doi: 10.1016/0002-9610(94)90119-8.
9
Vascular injury following cardiac catheterization, coronary angiography, and coronary angioplasty.
Eur Heart J. 1994 Feb;15(2):232-5. doi: 10.1093/oxfordjournals.eurheartj.a060481.
10
Bleeding complications with the chimeric antibody to platelet glycoprotein IIb/IIIa integrin in patients undergoing percutaneous coronary intervention. EPIC Investigators.
Circulation. 1995 Jun 15;91(12):2882-90. doi: 10.1161/01.cir.91.12.2882.